30 In 2001, Semax was introduced in Russia as 1% nasal drops for Parkinsons disease, encephalopathy, cerebral vascular accidents, and other vascular deficient pathologies of the brain
11 Clinical Pearls Patients should be counselled on the potential effects of their systemic medications on their ocular health and vision GLP-1 receptor agonists may serve an adjunct role in helping patients with IIH achieve optimal weight and guard against visual loss The current ophthalmic literature is varied with regard to GLP-1 receptor agonists and risk of NA-AION, and clinicians must stay informed as data continues to emerge on this topic References Mitchell JL, Lyons HS, Walker JK, et al
Molecular mechanisms of chromium in alleviating insulin resistance
Individual inflammatory baseline and immune capacity likely influence response
The second phase is dependent on ATP-producing secretagogues, which serves to underscore its energy dependence [21]
Abstract Oxidative stress is a critical feature of several common neurologic disorders
